Table of Contents

company-logo

Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.

Lexeo Therapeutics Dividend Announcement

• Lexeo Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Lexeo Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Lexeo Therapeutics Dividend History

Lexeo Therapeutics Dividend Yield

Lexeo Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lexeo Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Lexeo Therapeutics Financial Ratios

P/E ratio-2.76
PEG ratio0.04
P/B ratio1.72
ROE-57.66%
Payout ratio0.00%
Current ratio5.95
Quick ratio5.95
Cash Ratio5.86

Lexeo Therapeutics Dividend FAQ

Does Lexeo Therapeutics stock pay dividends?
Lexeo Therapeutics does not currently pay dividends to its shareholders.
Has Lexeo Therapeutics ever paid a dividend?
No, Lexeo Therapeutics has no a history of paying dividends to its shareholders. Lexeo Therapeutics is not known for its dividend payments.
Why doesn't Lexeo Therapeutics pay dividends?
There are several potential reasons why Lexeo Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Lexeo Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Lexeo Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Lexeo Therapeutics a dividend aristocrat?
Lexeo Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Lexeo Therapeutics a dividend king?
Lexeo Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Lexeo Therapeutics a dividend stock?
No, Lexeo Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Lexeo Therapeutics stocks?
To buy Lexeo Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Lexeo Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.